We are live on ! Find out more
MD icon

Pediatrix Medical

334 hedge funds and large institutions have $5.78B invested in Pediatrix Medical in 2014 Q2 according to their latest regulatory filings, with 44 funds opening new positions, 109 increasing their positions, 142 reducing their positions, and 22 closing their positions.

New
Increased
Maintained
Reduced
Closed

100% more first-time investments, than exits

New positions opened: 44 | Existing positions closed: 22

6% more funds holding

Funds holding: 314334 (+20)

0.13% less ownership

Funds ownership: 100.28%100.15% (-0.13%)

3% less call options, than puts

Call options by funds: $3.98M | Put options by funds: $4.09M

7% less capital invested

Capital invested by funds: $6.22B → $5.78B (-$435M)

17% less funds holding in top 10

Funds holding in top 10: 65 (-1)

23% less repeat investments, than reductions

Existing positions increased: 109 | Existing positions reduced: 142

Holders
334
Holders Change
+20
Holders Change %
+6.37%
% of All Funds
9.59%
Holding in Top 10
5
Holding in Top 10 Change
-1
Holding in Top 10 Change %
-16.67%
% of All Funds
0.14%
New
44
Increased
109
Reduced
142
Closed
22
Calls
$3.98M
Puts
$4.09M
Net Calls
-$114K
Net Calls Change
-$4.37M
Name Holding Trade Value Shares
Change
Change in
Stake
TD Asset Management
101
TD Asset Management
Ontario, Canada
$6.86M -$100K -1,700 -1%
PI
102
Placemark Investments
Illinois
$6.68M +$381K +6,471 +6%
Prudential Financial
103
Prudential Financial
New Jersey
$6.57M +$2.74M +46,490 +70%
Swiss National Bank
104
Swiss National Bank
Switzerland
$6.55M
Citadel Advisors
105
Citadel Advisors
Florida
$6.54M +$4.99M +84,859 +307%
ESCM
106
Echo Street Capital Management
New York
$6.53M +$6.61M +112,308 New
BPIM
107
Brant Point Investment Management
New York
$6.43M -$1.06M -18,000 -14%
SAM
108
Sentinel Asset Management
Vermont
$6.27M +$1.88M +31,900 +42%
ARC
109
Absolute Return Capital
Massachusetts
$6.2M +$5.99M +101,754 +2,131%
PCMI
110
Paradigm Capital Management Inc
New York
$5.91M +$659K +11,200 +12%
TPSF
111
Texas Permanent School Fund
Texas
$5.84M -$98.6K -1,676 -2%
PI
112
PineBridge Investments
New York
$5.8M +$3.9M +66,250 +198%
DIA
113
Dana Investment Advisors
Wisconsin
$5.64M -$220K -3,744 -4%
BTW
114
Boston Trust Walden
Massachusetts
$5.63M -$2.79M -47,471 -33%
Allianz Asset Management
115
Allianz Asset Management
Germany
$5.28M +$2.99M +50,878 +128%
AAM
116
Advisors Asset Management
Colorado
$5.18M +$298K +5,069 +6%
PPA
117
Parametric Portfolio Associates
Washington
$5.12M -$32.2K -547 -0.6%
MLICM
118
Metropolitan Life Insurance Company (MetLife)
New York
$4.99M -$74.1K -1,259 -1%
U
119
UBS
Switzerland
$4.91M -$2.88M -48,919 -37%
Natixis Advisors
120
Natixis Advisors
Massachusetts
$4.91M -$191K -3,245 -4%
BCMU
121
BlueCrest Capital Management (UK)
Guernsey
$4.76M +$4.82M +81,875 New
DCM
122
Dupont Capital Management
Delaware
$4.67M
TCM
123
Tygh Capital Management
Oregon
$4.66M -$298K -5,059 -6%
GH
124
GAM Holding
Switzerland
$4.65M -$1.52M -25,860 -24%
JIC
125
Johnson Investment Counsel
Ohio
$4.55M -$25.6K -435 -0.6%

MD Hedge Fund Activity: Q2 2014 in Review

334 of the 3,481 institutional investors tracked by Wall St. Rank reported a position in Pediatrix Medical (MD) for Q2 2014, worth a combined $5.78B — down 7% from $6.22B a quarter earlier.

Buyers outnumbered sellers: 44 funds opened new MD positions and 22 closed out — a net gain of 22 holders — while 109 added to existing stakes and 142 trimmed.

The largest buyer was Wells Fargo, adding an estimated $70.6M. The largest seller was Fidelity Investments, cutting an estimated $183M.

  • 334 institutional investors held Pediatrix Medical (MD) as of Q2 2014, up from 314 in Q1 2014.
  • Funds reported $5.78B of Pediatrix Medical stock for Q2 2014, down 7% quarter-over-quarter.
  • 44 funds opened new Pediatrix Medical positions in Q2 2014 and 22 closed out, a net change of +22 holders.
  • The largest Pediatrix Medical buyer in Q2 2014 was Wells Fargo, an estimated $70.6M added.
  • The largest Pediatrix Medical seller in Q2 2014 was Fidelity Investments, an estimated $183M sold.

Based on aggregated 13F filings for Q2 2014.